(Press-News.org) Toronto – A leading academic expert in household finance, Claire Célérier, who is an associate professor of finance at the University of Toronto’s Rotman School of Management, has been named by the Government of Canada as the Canada Research Chair in Household Finance.
Prof. Célérier’s research explores how finance can benefit households, investigating the role of innovation and the impact on diversity and inclusion. She addresses these questions taking different perspectives, from behavioral economics to asset pricing and history. Her work has been published in refereed academic journals, including the Quarterly Journal of Economics, Journal of Finance and Review of Financial Studies, and has raised the interest of the media, central banks and regulators around the world. She joined the Rotman School in 2016 from the University of Zurich, where she was an assistant professor. Prof. Célérier holds a PhD from the Toulouse School of Economics.
Established in 2000 by the Government of Canada, the Canada Research Chairs Program (CRCP) stands at the center of a national strategy to make Canada one of the world's top countries in research and development. It invests approximately $311 million per year to attract and retain a diverse cadre of world-class researchers, to reinforce academic research and training excellence in Canadian postsecondary institutions.
Bringing together high-impact faculty research and thought leadership on one searchable platform, the Rotman Insights Hub offers articles, podcasts, opinions, books and videos representing the latest in management thinking and providing insights into the key issues facing business and society. Visit www.rotman.utoronto.ca/insightshub.
The Rotman School of Management is part of the University of Toronto, a global centre of research and teaching excellence at the heart of Canada’s commercial capital. Rotman is a catalyst for transformative learning, insights and public engagement, bringing together diverse views and initiatives around a defining purpose: to create value for business and society. For more information, visit www.rotman.utoronto.ca
-30-
For more information:
Ken McGuffin
Manager, Media Relations
Rotman School of Management
University of Toronto
E-mail:mcguffin@rotman.utoronto.ca
END
Canada Research Chair awarded to finance professor at the Rotman School of Management
2024-03-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Water droplet spun by sound screens for colon cancer
2024-03-13
DURHAM, N.C. – Mechanical engineers at Duke University have devised a new type of diagnostic platform that uses sound waves to spin an individual drop of water up to 6,000 revolutions per minute. These speeds separate tiny biological particles within samples to enable new diagnostics based on exosomes.
A very light disc placed on top of the spinning drop features etched channels that are equipped with star-shaped nanoparticles tailored to enable the label-free detection of specific disease-relevant bioparticles called exosomes. The technique ...
Study: Default testing for COVID-19 in K-12 schools more effective than voluntary testing
2024-03-13
CHAMPAIGN, Ill. — A new paper co-written by a team of University of Illinois Urbana-Champaign business professors found that default testing of K-12 students for COVID-19 during the pandemic could have saved up to one out of every five school days lost to the coronavirus during the fall 2021 semester.
Schools adopting an “opt-out model” – in which students were regularly tested for COVID-19 unless they proactively declined or “opted out” of testing – experienced a 30% lower positivity rate than schools ...
Poor sleep linked to migraine attacks in new UArizona Health Sciences study
2024-03-13
A new study by researchers at the University of Arizona Health Sciences identified a link between poor sleep and migraine attacks that suggests improving sleep health may diminish migraine attacks in people with migraine.
Many people with migraine report having sleeping disorders, including insomnia, trouble falling or staying asleep, poor sleep quality, excessive daytime sleepiness, waking up from sleep and being forced to sleep because of a migraine headache. Until now, it was unknown ...
Next generation stool DNA test has best detection rate of noninvasive colorectal cancer screening tools
2024-03-13
INDIANAPOLIS -- A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas Imperiale, M.D., has found that the next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers. This test has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
Study results are published in the New England Journal of Medicine.
“We found that the next generation stool DNA test ...
Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer
2024-03-13
SEATTLE — March 14, 2024 — A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a study published March 14 in the New England Journal of Medicine.
The accuracy rate for colorectal cancer is similar to at-home stool tests used for early detection of colorectal cancer.
“The results of the study are a promising step toward developing more convenient tools to detect colorectal cancer early while it is more easily treated,” said corresponding ...
Preliminary clinical trial results show ‘dramatic and rapid’ regression of glioblastoma after next generation CAR-T therapy
2024-03-13
A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment. In a paper published today in The New England Journal of Medicine, researchers from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, shared the results for the first three patient cases from a phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma (GBM). The trial, known as INCIPIENT, is designed to evaluate the safety of CARv3-TEAM-E T cells in patients with recurrent GBM. Just days after a single ...
Asian aerosols’ impact on Atlantic Meridional Overturning Circulation
2024-03-13
By Linh Truong
Since the Atlantic Meridional Overturning Circulation (AMOC) was first monitored in 2004, it has been the focus of thousands of scientific papers and even a blockbuster movie that grossed more than $552 million worldwide.
New research is hoping to add another twist to the current conversation.
Published in Nature Communications, Increased Asian Aerosols Drive a Slowdown of Atlantic Meridional Overturning Circulation identifies the effect of aerosols over Asia on the AMOC, a complex system of currents in the Atlantic Ocean.
Jian Lu, Earth scientist at the Department ...
Long COVID patients report improvements following self-regulation therapy, study finds
2024-03-13
A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies.
The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long COVID patients, many of whom had been experiencing symptoms for more than a year. Each participant underwent six sessions of biofeedback therapy, which involves the practice of breathwork and relaxation techniques paired with visual feedback to teach self-regulation of autonomic functions such as heart rate and temperature.
Clinical psychologist Dr. Natacha Emerson, the study’s lead author and assistant clinical professor ...
Novel oral hormone therapy shows promising results for prostate cancer treatment with radiation therapy
2024-03-13
CLEVELAND - A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. This work is published in JAMA Oncology.
This research, encompassing an individual patient level analysis from two multinational randomized clinical trials, showcases relugolix's ability to rapidly achieve and maintain low testosterone levels, a necessary condition for some men’s prostate cancer treatment, in both short-term ...
Do astronauts experience “space headaches”?
2024-03-13
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MARCH 13, 2024
MINNEAPOLIS – Space travel and zero gravity can take a toll on the body. A new study has found that astronauts with no prior history of headaches may experience migraine and tension-type headaches during long-haul space flight, which includes more than 10 days in space. The study was published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“Changes in gravity caused by space flight affect the function of many parts of the body, including the brain,” said study author W. P. J. van Oosterhout, MD, PhD, of Leiden University ...